Clinical Trials Directory

Trials / Sponsors / Meiji Seika Pharma Co., Ltd.

Meiji Seika Pharma Co., Ltd.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedP3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available T
Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia
Phase 32023-09-22
CompletedEfficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects
Complicated Urinary Tract Infection, Acute Pyelonephritis, cUTI
Phase 32023-05-23
CompletedA Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subje
Healthy Volunteer
Phase 12016-08-01
CompletedA Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution
Pneumonia, Bacterial
Phase 12015-09-01
CompletedA Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595
Healthy Volunteers, Bacterial Infections
Phase 12014-05-01
CompletedBioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adul
Healthy Volunteer
Phase 12014-01-01
CompletedEfficacy and Safety Study of ME1111 in Patients With Onychomycosis
Onychomycosis
Phase 22013-12-19
CompletedIntrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers
Healthy
Phase 12013-09-01
CompletedPharmacokinetics and Safety Study of ME1100 in Healthy Volunteers
Healthy
Phase 12013-07-01
CompletedPharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients
Onychomycosis
Phase 12013-03-01